Following androgen deprivation of an orthotopic mouse PTEN-deleted prostate tumor, the stimulation of AKT led to elevated levels of mitochondrial hexokinase 2 (HK2), and metabolic reprogramming was observed [146]. The gene discussed is AKT1; the disease is prostate neoplasm.